Analysts: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

800.70
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
800.70₪
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
125,277
52-wk High
1,845.00₪
52-wk Low
713.00₪

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.01 December 22 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 1 1 1
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.40 2.40 2.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 3 15.69 27.40 7.27 12.80
Quarter Ending Mar-15 1 11.75 11.75 11.75 --
Year Ending Dec-14 3 35.79 45.20 21.00 39.73
Year Ending Dec-15 3 57.30 63.79 47.60 63.84
Earnings (per share)
Quarter Ending Dec-14 3 -0.01 0.01 -0.04 0.01
Quarter Ending Mar-15 1 -0.04 -0.04 -0.04 --
Year Ending Dec-14 2 -0.17 -0.07 -0.27 -0.05
Year Ending Dec-15 2 -0.09 0.00 -0.17 0.33

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 5.70 3.57 2.13 37.38
Quarter Ending Dec-12 7.75 1.17 6.58 84.88
Quarter Ending Sep-12 2.68 3.72 1.04 38.82
Quarter Ending Jun-12 14.80 25.26 10.46 70.69
Quarter Ending Mar-12 2.13 3.86 1.74 81.65

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 15.69 15.69 14.58 16.37 12.80
Quarter Ending Mar-15 11.75 11.75 11.72 -- --
Year Ending Dec-14 35.79 35.79 28.32 38.24 39.73
Year Ending Dec-15 57.30 57.30 58.18 61.83 63.84

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 0 0
Quarter Ending Mar-15 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks